Anti-Factor Xa Activity Test System, Apixaban
QLU is the FDA product code for Anti-Factor Xa Activity Test System, Apixaban, a class II device type, regulated under 21 CFR 864.7295. FDA's definition for this code reads: "A heparin and direct oral factor Xa inhibitor drug test system is intended for the detection of heparin and direct oral factor Xa inhibitors in human specimens collected from patients taking heparin or direct oral factor Xa inhibitors. This device is intended to aid in the management of therapy in conjunction with...". As of , FDA records hold 3 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- QLU
- Device name
- Anti-Factor Xa Activity Test System, Apixaban
- FDA definition
- A heparin and direct oral factor Xa inhibitor drug test system is intended for the detection of heparin and direct oral factor Xa inhibitors in human specimens collected from patients taking heparin or direct oral factor Xa inhibitors. This device is intended to aid in the management of therapy in conjunction with other clinical and laboratory findings.
- Regulation
- 21 CFR 864.7295
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 3
- Ingested recalls
- 1
Clearances, product code QLU
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Applicants with the most clearances
Product code QLU| Applicant | Clearances |
|---|---|
| Instrumentation Laboratory Co. | 2 |
| Siemens Healthcare Diagnostics Products Limited | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
